← Pharmacy curriculum
Module 035 submodulesSystems therapeutics

Cardiovascular II and Renal

Advance into atherosclerotic disease, thrombosis, rhythm disorders, heart failure, stroke, and kidney disease.

01

Connect cardiovascular pathophysiology to drug targets.

02

Distinguish antiplatelet and anticoagulant roles.

03

Recognize rhythm and heart-failure treatment priorities.

04

Adjust assessment when kidney function changes.

03.01

Submodule

Dyslipidemia, Coronary Disease, and ACS

Atherosclerotic risk reduction and acute coronary treatment require different time horizons but share lipid, platelet, ischemia, and prevention pathways.

What to learn
  • Lipoproteins and atherosclerotic risk
  • Statins and nonstatin therapy
  • Stable coronary disease
  • Acute coronary syndrome and secondary prevention
03.02

Submodule

Anticoagulation and Venous Thromboembolism

Anticoagulant selection depends on the indication, timing, renal and hepatic function, bleeding risk, interactions, adherence, and route.

What to learn
  • Coagulation pathway targets
  • Heparins, warfarin, and direct oral anticoagulants
  • DVT and pulmonary embolism treatment phases
  • Bleeding assessment, reversal, and counseling
03.03

Submodule

Arrhythmias and ECG Reasoning

Rhythm management combines electrical conduction, symptom severity, stroke risk, ventricular response, and drug-specific proarrhythmic risk.

What to learn
  • Rate, rhythm, intervals, and conduction
  • Atrial and ventricular arrhythmias
  • Rate control, rhythm control, and anticoagulation
  • QT prolongation and antiarrhythmic monitoring
03.04

Submodule

Heart Failure and Peripheral Arterial Disease

Heart failure treatment addresses congestion, maladaptive neurohormonal signaling, symptoms, hospitalization, and survival, while peripheral arterial disease requires vascular risk reduction and functional assessment.

What to learn
  • Ejection fraction and clinical phenotype
  • Guideline-directed chronic therapy
  • Acute decompensation and diuresis
  • Peripheral arterial disease and vascular prevention
03.05

Submodule

Stroke, Acute Kidney Injury, and Chronic Kidney Disease

Neurologic and renal emergencies require rapid recognition, while long-term prevention depends on identifying causes, complications, and medication-related risk.

What to learn
  • Ischemic versus hemorrhagic stroke
  • Acute stroke timelines and secondary prevention
  • AKI recognition and nephrotoxic exposure
  • CKD staging, complications, and renal replacement therapy

Module test

Check the connections.

Answer one question from each submodule. Submit the full set to reveal the reasoning.

0 of 5 answered
01Which medication class is foundational for lowering LDL cholesterol and reducing atherosclerotic cardiovascular risk?
02What is the most important first step when reviewing an anticoagulant dose?
03Why is the QT interval important when reviewing several antiarrhythmic drugs?
04Which finding most strongly suggests congestion in heart failure?
05Which medication review is most urgent when acute kidney injury develops?
Answer every question to submit.
PharmacyOpen tools